Antimicrobial Consumption in Latin American Countries: First Steps of a Long Road Ahead

dc.contributor.authorMarin, Gustavo H.
dc.contributor.authorGiangreco, Lucia
dc.contributor.authorDorati, Cristian
dc.contributor.authorMordujovich, Perla
dc.contributor.authorBoni, Silvia
dc.contributor.authorMantilla-Ponte, Hilda
dc.contributor.authorAlfonso Arvez, Ma Jose
dc.contributor.authorLopez Pena, Monica
dc.contributor.authorAldunate Gonzalez, Ma Francisca
dc.contributor.authorFung, Shing Mi Ching
dc.contributor.authorBarcelona, Laura
dc.contributor.authorCampana, Laura
dc.contributor.authorVaquero Orellana, Alejandra
dc.contributor.authorOrjuela Rodriguez, Tatiana
dc.contributor.authorGines Cantero, Larissa
dc.contributor.authorVillar, Rosa A.
dc.contributor.authorSandoval Fuentes, Nicole
dc.contributor.authorMelero, Emiliano
dc.contributor.authorMarin-Piva, Hugo
dc.contributor.authorSoler, Gisela
dc.contributor.authorGabriel, Fernanda
dc.contributor.authorPineda Velandia, Laura
dc.contributor.authorOjeda Florentin, Cinthia
dc.contributor.authorRisso Patron, Soledad
dc.contributor.authorOrtiz Rivas, Mariela
dc.contributor.authorMendoza Benitez, Carolina
dc.contributor.authorMellado, Rosemarie
dc.contributor.authorIvanovska, Verica
dc.contributor.authorMuller, Arno
dc.contributor.authorRojas, Robin
dc.contributor.authorCastro, Jose Luis
dc.date.accessioned2025-01-20T21:08:53Z
dc.date.available2025-01-20T21:08:53Z
dc.date.issued2022
dc.description.abstractBackground: Irrational antimicrobial consumption (AMC) became one of the main global health problems in recent decades. Objective: In order to understand AMC in Latin-American Region, we performed the present research in 6 countries. Methods: Antimicrobial consumption (J01, A07A, POI AB groups) was registered in Argentina, Chile, Colombia, Costa Rica, Paraguay, and Peru. Source of information, AMC type, DDD (Defined Daily Doses), DID (DDD/1000 inhabitants/day), population were variables explored. Data was analyzed using the Global Antimicrobial Resistance and Use Surveillance System (GLASS) tool. Results: Source of information included data from global, public, and private sectors. Total AMC was highly variable (range 1.91-36.26 DID). Penicillin was the most consumed group in all countries except in Paraguay, while macrolides and lincosamides were ranked second. In terms of type of AMC according to the WHO-AWaRe classification, it was found that for certain groups like "Reserve," there are similarities among all countries. Conclusion and Relevance: This paper shows the progress that 6 Latin-American countries made toward AMC surveillance. The study provides a standardized approach for building a national surveillance system for AMC data analysis. These steps will contribute to the inclusion of Latin-America among the regions of the world that have periodic, regular, and quality data of AMC.
dc.fuente.origenWOS
dc.identifier.doi10.1177/21501319221082346
dc.identifier.eissn2150-1327
dc.identifier.issn2150-1319
dc.identifier.urihttps://doi.org/10.1177/21501319221082346
dc.identifier.urihttps://repositorio.uc.cl/handle/11534/93499
dc.identifier.wosidWOS:000786489400001
dc.language.isoen
dc.revistaJournal of primary care and community health
dc.rightsacceso restringido
dc.subjectantimicrobial
dc.subjectconsumption
dc.subjectdata source
dc.subjectinformation
dc.subjectGLASS
dc.subjectLatin America
dc.subject.ods03 Good Health and Well-being
dc.subject.odspa03 Salud y bienestar
dc.titleAntimicrobial Consumption in Latin American Countries: First Steps of a Long Road Ahead
dc.typeartículo
dc.volumen13
sipa.indexWOS
sipa.trazabilidadWOS;2025-01-12
Files